Supernus Pharmaceuticals, Inc.
🏢 View company profile →80Patents
74Active
80Granted
52Portfolio score
Filing activity: May 12, 2003 → Jan 18, 2024 · 23 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7611728B2 | Osmotic delivery of therapeutic compounds by solubility enhancement | Human Necessities | 69 | Expired |
| US8598191B2 | Controlled release compositions of gamma-hydroxybutyrate | Human Necessities | 69 | Active |
| US8193211B2 | Controlled release compositions of gamma-hydroxybutyrate | Human Necessities | 65 | Active |
| US8747897B2 | Osmotic drug delivery system | Human Necessities | 44 | Active |
| US7910128B2 | Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics | Human Necessities | 39 | Active |
| US8617600B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 26 | Active |
| US8906413B2 | Drug formulations having reduced abuse potential | Human Necessities | 20 | Expired |
| US7410978B2 | Once daily dosage forms of trospium | Human Necessities | 11 | Expired |
| US7749532B2 | Once daily formulations of tetracyclines | Human Necessities | 10 | Active |
| US7763635B2 | Once daily dosage forms of trospium | Human Necessities | 10 | Active |
| US8470364B2 | Once daily formulations of tetracyclines | Human Necessities | 7 | Active |
| US8206740B2 | Once daily formulations of tetracyclines | Human Necessities | 7 | Active |
| US8298580B2 | Sustained-release formulations of topiramate | Emerging Cross-Sectional Technologies | 7 | Active |
| US8394406B2 | Once daily formulations of tetracyclines | Human Necessities | 6 | Active |
| US8394405B2 | Once daily formulations of tetracyclines | Human Necessities | 6 | Active |
| US8748472B2 | Stabilized formulations of CNS compounds | Human Necessities | 6 | Active |
| US8709478B2 | Once daily formulations of tetracyclines | Human Necessities | 5 | Active |
| US9119792B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 5 | Active |
| US7722898B2 | Modified-release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 4 | Active |
| US8957206B2 | Methods of producing molindone and its salts | Chemistry; Metallurgy | 4 | Active |
| US9358204B2 | Formulations of viloxazine | Human Necessities | 3 | Active |
| US9662338B2 | Formulations of viloxazine | Human Necessities | 3 | Active |
| US7910131B2 | Method of treating seizures using modified release formulations of oxcarbazepine | Human Necessities | 3 | Active |
| US8663683B2 | Sustained-release formulations of topiramate | Emerging Cross-Sectional Technologies | 3 | Active |
| US10265319B2 | Formulations of viloxazine | Human Necessities | 3 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.